Menard Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-174
| Closed | -$90.5K | – | 285 |
|
|
2024
Q4 | $90.5K | Buy |
+174
| New | +$90.5K | 0.05% | 154 |
|
|
2024
Q1 | – | Sell |
-785
| Closed | -$417K | – | 109 |
|
|
2023
Q4 | $417K | Hold |
785
| – | – | 0.52% | 48 |
|
|
2023
Q3 | $397K | Buy |
785
+44
| +6% | +$22.3K | 0.57% | 43 |
|
|
2023
Q2 | $387K | Sell |
741
-14
| -2% | -$7.31K | 0.79% | 27 |
|
|
2023
Q1 | $435K | Buy |
755
+14
| +2% | +$8.07K | 1.01% | 29 |
|
|
2022
Q4 | $408K | Hold |
741
| – | – | 0.97% | 27 |
|
|
2022
Q3 | $376K | Sell |
741
-1,063
| -59% | -$539K | 0.68% | 41 |
|
|
2022
Q2 | $980K | Sell |
1,804
-780
| -30% | -$424K | 1.6% | 17 |
|
|
2022
Q1 | $1.53M | Buy |
2,584
+122
| +5% | +$72K | 1.5% | 10 |
|
|
2021
Q4 | $1.64M | Buy |
2,462
+734
| +42% | +$490K | 1.35% | 15 |
|
|
2021
Q3 | $987K | Buy |
1,728
+171
| +11% | +$97.7K | 0.87% | 21 |
|
|
2021
Q2 | $785K | Buy |
1,557
+74
| +5% | +$37.3K | 0.74% | 31 |
|
|
2021
Q1 | $677K | Sell |
1,483
-116
| -7% | -$53K | 0.73% | 32 |
|
|
2020
Q4 | $745K | Buy |
1,599
+119
| +8% | +$55.4K | 0.8% | 30 |
|
|
2020
Q3 | $653K | Buy |
1,480
+107
| +8% | +$47.2K | 0.76% | 32 |
|
|
2020
Q2 | $497K | Buy |
+1,373
| New | +$497K | 0.62% | 34 |
|
|
2020
Q1 | – | Sell |
-2,196
| Closed | -$713K | – | 110 |
|
|
2019
Q4 | $713K | Buy |
+2,196
| New | +$713K | 0.69% | 46 |
|